Pure Bioscience, Inc. (PURE) stock
PUREOTCMiscellaneous Chemical ProductsFiscal year ends July 31
$0.07−0.01 (-12.10%)
Close on Oct 19, 2026Market cap $8.67MP/E –Yield –
Earnings
Pure Bioscience's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Next report
Dec 14, 2026
Q1 FY2027 · estimated, during market hours
Revenue, Q3 FY2026
$506.00K
+3.1% on a year earlier
EPS, Q3 FY2026
-$0.01
-$0.01 a year earlier
Latest guidance
None
No outlook given in releases
Quarterly results
Revenue and earnings per share from each of Pure Bioscience's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Source |
|---|---|---|---|---|---|
| Q1 FY2027ended Oct 31, 2026 | Dec 14, 2026Expected | – | – | – | – |
| Q4 FY2026ended Jul 31, 2026 | Oct 29, 2026after the close | – | – | – | Release |
| Q3 FY2026ended Apr 30, 2026 | Jun 15, 2026during market hours | $506.00K | +3.1% | -$0.01 | Release |
| Q2 FY2026ended Jan 31, 2026 | Mar 17, 2026after the close | $444.00K | +13.6% | -$0.01 | Release |
| Q1 FY2026ended Oct 31, 2025 | Dec 15, 2025during market hours | $708.00K | +27.3% | $0.00 | Release |
| Q4 FY2025ended Jul 31, 2025 | Oct 29, 2025during market hours | – | – | – | Release |
| Q3 FY2025ended Apr 30, 2025 | Jun 16, 2025during market hours | $491.00K | – | -$0.01 | Release |
| Q2 FY2025ended Jan 31, 2025 | Mar 17, 2025during market hours | $391.00K | – | -$0.01 | Release |
| Q1 FY2025ended Oct 31, 2024 | Dec 16, 2024during market hours | $556.00K | – | -$0.01 | Release |
| Q4 FY2024ended Jul 31, 2024 | Oct 29, 2024during market hours | – | – | – | Release |
| Q3 FY2024ended Apr 30, 2024 | Jun 14, 2024during market hours | – | – | – | Release |
| Q2 FY2024ended Jan 31, 2024 | Mar 18, 2024during market hours | – | – | – | Release |
| Q1 FY2024ended Oct 31, 2023 | Dec 14, 2023during market hours | – | – | – | Release |
| Q4 FY2023ended Jul 31, 2023 | Oct 30, 2023during market hours | – | – | – | Release |
| Q3 FY2023ended Apr 30, 2023 | Jun 14, 2023during market hours | – | – | – | Release |
| Q2 FY2023ended Jan 31, 2023 | Mar 17, 2023during market hours | – | – | – | Release |
| Q1 FY2023ended Oct 31, 2022 | Dec 14, 2022during market hours | – | – | – | Release |
| Q4 FY2022ended Jul 31, 2022 | Oct 28, 2022during market hours | – | – | – | Release |
| Q3 FY2022ended Apr 30, 2022 | Jun 14, 2022during market hours | – | – | – | Release |
| Q2 FY2022ended Jan 31, 2022 | Mar 15, 2022during market hours | – | – | – | Release |
| Q1 FY2022ended Oct 31, 2021 | Dec 15, 2021during market hours | – | – | – | Release |
| Q4 FY2021ended Jul 31, 2021 | Oct 28, 2021during market hours | – | – | – | Release |
| Q3 FY2021ended Apr 30, 2021 | Jun 15, 2021during market hours | – | – | – | Filing |
| Q2 FY2021ended Jan 31, 2021 | Mar 15, 2021during market hours | – | – | – | Filing |
| Q1 FY2021ended Oct 31, 2020 | Dec 15, 2020during market hours | – | – | – | Filing |
| Q4 FY2020ended Jul 31, 2020 | Oct 8, 2020during market hours | – | – | – | Filing |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Guidance
Pure Bioscience has not given guidance in its releases
Many companies give their outlook only on the conference call or not at all. When Pure Bioscience puts a forecast in an earnings release, it is listed here with the exact sentence.
Press releases
Releases Pure Bioscience filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Results
See a number that looks wrong?